Company Data
Immix Biopharma Inc.
Ticker
IMMX
Current Price
$4.8 15.66%
Market Cap
$161.2M
Price Target
Refer to Report
Volume
1.1M
52wk Range
$1.34 - $4.6
Overview
Immix Biopharma Inc is a clinical-stage biopharmaceutical company developing Tissue-Specific Therapeutics in oncology and inflammation. Its product candidate drug candidates to circulate in the bloodstream, exit through tumor blood vessels and simultaneously attack all components of the TME.